StoneX Group’s Jupiter Neurosciences JUNS Stock Holding History

StoneX Group’s Portfolio JUNS Stock Details JUNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-275	Closed	-$5.68K	–	2243
2026 Q2	$5.68K	Buy	+275	New	+$6.5K	﹤0.01%	1405

Other funds holding JUNS

Vestor Capital Chicago, Illinois $1.62B AUM 33.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

StoneX Group's JUNS Position: Q3 2026 in Review

StoneX Group sold out of Jupiter Neurosciences (JUNS) in Q3 2026, closing a stake of 275 shares — an estimated $5.68K sold.

StoneX Group first reported a position in JUNS in Q2 2026 and held it in 1 quarter. The position peaked at $5.68K in Q2 2026. 5 funds tracked by Wall St. Rank hold JUNS as of Q3 2026.

StoneX Group reported no remaining Jupiter Neurosciences position as of Q3 2026 after selling out during the quarter.
StoneX Group sold 275 Jupiter Neurosciences shares in Q3 2026, an estimated $5.68K.
StoneX Group first reported a position in Jupiter Neurosciences in Q2 2026 and held it in 1 quarter.
StoneX Group's Jupiter Neurosciences position peaked at $5.68K in Q2 2026.
5 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.